Clinical trials query results
From Health Canada
- Medical condition:
- ANXIETY DISORDER
- Medical condition:
- ADULT FEMALE,ADULT MALE
- Drug name:
- PSILOCYBIN
- Protocol title:
- A PHASE 2A, PLACEBO-CONTROLLED RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND PRELIMINARY EFFICACY OF PSILOCYBIN ORAL SOLUTION IN ADULTS WITH GENERALIZED ANXIETY DISORDER
- Sponsor name:
- DIAMOND THERAPEUTICS
- Date of no objection letter:
- 2024-01-18
- Control number:
- 282159
- Trial status:
- PENDING